Trevena, Inc. (TRVN) - NASDAQ
From other sites
Company Description
Trevena, Inc. is a clinical stage biopharmaceutical company, which discovers, develops and intends to commercialize therapeutics that use a novel approach to target G protein coupled receptors. Its product pipeline consists of TRV027, which is an intravenous drug for the treatment of acute heart... More
Sector: Healthcare
Industry: Biotechnology
Country: United States